Incidence and Prevalence: What do they mean, how new numbers are identified and why they are important?
Incidence and prevalence are two terms that are frequently used in epidemiology but are often mixed up or used incorrectly. Epidemiology is a branch of research that…
Diet and MS: What does research tell us about supplements?
A question I frequently receive is: “Are there supplements I can take to manage my MS?” MS impacts the day-to-day lives of those…
Minocycline and MS: How Jill is living MS free
I recently had the opportunity to speak with Jill, a Minocycline phase III trial participant, to talk about her involvement in the study.…
The ins and outs of clinical trials
So what does it cost to run a clinical trial, anyway? Performing a clinical trial requires a great deal of resources. Namely, time,…
An important milestone in MS research and hope for people living with progressive MS
Guest post by Cory Turner – member of the MS Scientific Research Foundation Board We don’t get to pick when we’re diagnosed with…
When progress becomes a bad word
By Chantal Milne – on the Canadian MS Progression Cohort When I found out I was pregnant, I eagerly downloaded two pregnancy apps,…
Hacking health: What can technology teach us about multiple sclerosis?
Technology … meet the health care industry. Last fall we attended Canada’s first university-organized medical hackathon – a 36-hour event called Hack4Health…
Tech development for MS symptom management
“Are you sure I can’t offer you tea?” Mrs. Bokhari, standing in the lobby of a high rise on the edge of Waterloo,…
Taking a risk: Canadian Bone Marrow Transplantation trial
by Jennifer Molson Still, knowing what I know now, I would do it all over again. I won’t sugar coat this: the trial…
